Apnimed, Inc.

NASDAQ:APMD

Biotechnology

Healthcare
$17.45 +2.84%

+$0.71 today

Market cap
$726.46M
Beta
0.00

Volume 0.30M

Average 1.15M

APMD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

No reported Research & Development figures are available to summarize.

Research & Development history

Currency unavailable · from the income statement

No Research & Development data reported for this period type.

Research & Development vs competitors

How APMD compares with its peers on the latest reported figures

APMD Competitors
Research & Development for APMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSPInspire Medical Systems, Inc.LTM Jun 2026$99.68M USD-9.7%+14.5%11.1%
NYXHNyxoah S.A.LTM Mar 2026€42.56M EUR+17.3%+39.2%260.8%
APMDApnimed, Inc.—— ———
Peer median (excluding APMD) —+3.8%+26.9%135.9%

Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Apnimed, Inc.

NASDAQ:APMD

Intrinsic Alpha fair value

Locked

Current Price

$17.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.